Follow-up Study for Participants Jointstem Clinical Trial

Biostar Stem Cell Research Institute (R-Bio)

Status and phase: Completed; Phase 2

Conditions: Knee Osteoarthritis

Treatments: Drug: Jointstem

Study type: Interventional

Funder types: Industry

Identifiers

NCT03509025

JM2b-FU

Details and patient eligibility

About

This study is a long term follow-up study to investigate the safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Knee Osteoarthritis.

Enrollment: 11 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients must consent in writing to participate in the study by signing and dating an informed consent document
• Patients who transplanted Jointstem on phase 2b clinical trial

Exclusion criteria

• Preparing for Pregnancy or Pregnant women or lactating mothers.
• Patients who the principal investigator considers inappropriate for the clinical tria

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

11 participants in 1 patient group

Long Term Follow-up after Jointstem Transplantation

Experimental group

Treatment:

Drug: Jointstem